Providing the healthcare sector with innovative, cutting-edge analytical services.

We are driven by our passion for innovation and our commitment to providing the best possible service to our clients. Our state-of-the-art technology and cutting-edge analytical methods allow us to meet the demands of various sectors within the healthcare domain.

Learn More

Working together to achieve great things

The National Metabolomics Platform (NMP), in partnership with the Technology Innovation Agency (TIA), an entity of the Department of Science, Technology and Innovation (DSTI) is hosted at NWU’s Centre for Human Metabolomics (CHM). The NMP was established to fulfil a niche in the South African Healthcare sector by providing internationally competitive, effective, and efficient Metabolomics Analytic Services. 

The NMP* is at the forefront of promoting and maximising scientific technological advancements for the benefit of all.

*Services were formerly provided as PLIEM – Potchefstroom Laboratory for Inborn Errors of Metabolism.

The MISSION of CHM is to provide analytical, training and consultancy services in accordance with the best applicable standards, as well as to deliver valuable research outputs, meeting the requirements and expectations of its customers and the NWU.  The management and staff of CHM undertake to ensure that all activities carried out are in strict accordance with the laboratory’s SOP’s and comply with the ISO 15189 requirements for all testing. 

The VISION of the CHM is to be an ISO 15189 accredited facility that addresses a specific need in the South African and international health sector and to be a globally recognised expert centre for inherited metabolic disease and metabolomics services.
Read More

We host weekly CPD accredited webinars, join our mailing list to receive dates and topics via email. All previous webinars can be found on our YouTube channel.

CPD lecture series 2026
Join Our Mailing List

Find our Webinars

Latest News

Annual Report 2025

Annual Report 2025

February 13, 2026 Reports

November 2024 – November 2025

Read More
Partnership Spotlight: NMP and Breathtaking Fundraising Unite to Advance CF Awareness and Newborn Screening

Partnership Spotlight: NMP and Breathtaking Fundraising Unite to Advance CF Awareness and Newborn Screening

November 25, 2025 News

The National Metabolomics Platform (NMP) is proud to announce a meaningful new partnership with Breathtaking

Read More

Join Our Mailing List

accelRare® is a pre-diagnostic solution for rare diseases. accelRare® uses the medvir tool, certified as a Class I medical device, for which Medical Intelligence Service is the manufacturer and Sanofi the distributor.

Read More

Receive the Form with PDF Attachment

To obtain a copy of this form as PDF attachment for printing, please provide your email address below.

Provide clinical information

Clinical information may greatly assist in the interpretation of metabolic results and additional recommendations. The clinical information can be provided here

Print the test selection form from email and hand to the patient or phlebotomist for sample collection

[field id="reference_id"]
[field id="imdclinicalresult1"]

The National Metabolomics Platform is a specialized laboratory dedicated to diagnosing rare and inherited metabolic diseases. Located on the Potchefstroom campus of North-West University, the laboratory may occasionally require additional tests, including genetic testing, to confirm a diagnosis. If these tests incur additional costs, the laboratory will seek prior approval from you and/or your clinician. To ensure diagnostic accuracy, clinical information and other reports may also be requested. Such requests are made solely to enhance the precision of the diagnosis. Following a diagnosis, the laboratory may contact you about potential research projects for which you might be eligible. These projects aim to improve the understanding and characterization of rare diseases and offer patients opportunities to participate in international clinical trials. Participation in these projects is entirely voluntary, and there is no obligation to take part if contacted. All research is conducted under the oversight of the NWU Health Research Ethics Committee.

GCxGC-TOFMS Untargeted

  • Sample matrix (Volume needed):
  • Serum (100-200 uL)
  • Urine (1-2 mL)
  • Tissue (100 mg)
  • Other (Please consult)
  • Analytical Technique:
  • GCxGC-TOFMS
Enquire Now
Download pdf

Compound list

Spectra identified via comparison with library spectra

NMR Untargeted

  • Sample matrix (Volume needed):
  • Serum (1,5mL)
  • Urine (1-2mL)
  • CSF (150 - 200 uL)
  • Breastmilk (2-3 mL)
  • Tissue (100 mg)
  • Other (Please consult)
  • Analytical Technique:
  • NMR
Enquire Now
Download PDF

Compound list

Spectra identified via comparison with library spectra

LDL Cholesterol Subfractions

  • Sample matrix (Volume needed):
  • Fasting Serum (50 - 100 uL)

  • Price per sample (VAT incl):
  • R 900 (Client should provide total cholesterol value)
  • Analytical Technique:
  • Lipoprint - Gel Electrophoresis
Enquire Now
Download PDF

Compound list

The LDL subfraction test measures up to twelve lipoprotein fractions and subfractions (VLDL, mid-bands A-C and LDL 1 through 7)

HDL Cholesterol Subfractions

  • Sample matrix (Volume needed):
  • Fasting Serum (50 - 100 uL)

  • Price per sample (VAT incl):
  • R 900 (Client should provide total cholesterol value)
  • Analytical Technique:
  • Lipoprint - Gel Electrophoresis
Enquire Now
Download PDF

Compound list

Separates and quantifies up to 10 HDL subfractions, classified from large buoyant HDL lipoproteins (HDL-L) to small-dense HDL lipoproteins (HDL-S).